Skip to Content
Home›Case studies›Pharmaceuticals & Medical Devices
Illustration: Pharmaceuticals & Medical Devices
Sector case study

Pharmaceuticals & Medical Devices: the cost of the gap, and how to measure it

The pharmaceutical and medical device sector in Morocco is undergoing significant changes, marked by regulatory challenges, technological advancements, and rising consumer expectations. In this context, companies must adapt their strategies to remain competitive. This sector case study aims to analyse current issues and propose avenues for improvement for industry players.

Method warning

A typical case, not a client

This study does not describe any real clients and does not report any results obtained from a client: our confidentiality commitments prohibit this. It sets out explicit working hypotheses, then derives orders of magnitude through calculations that you can replicate line by line. During a diagnosis, your figures replace ours.

The starting point

The modelled situation

The Moroccan pharmaceutical market is constantly evolving, influenced by factors such as population growth, urbanisation and changes in lifestyles. Companies must navigate a complex environment, where regulation structures the operating conditions. Patient expectations regarding quality and accessibility of care are rising, which pushes companies to review their approaches. Moreover, digitalisation enables the optimisation of processes and the improvement of customer experience. The above assumptions allow for a better understanding of market dynamics and the identification of opportunities to seize.

Initial hypothesisValueUnit
Regulatory requirements to cover130requirements
Relevant processes20process
People to be trained85people
Evidence documents by requirement3documents
The calculation

Result, line by line

Analysis of market trends in the pharmaceutical and medical devices sector in Morocco reveals significant challenges and opportunities. Companies must adapt to a constantly changing environment, where regulation and consumer expectations are central. By focusing on innovation, digitalisation and improved customer experience, sector players can not only meet current requirements, but also anticipate future developments. The above assumptions highlight the importance of a proactive approach to navigating this complex and changing landscape.

Calculated magnitudeFormulaResultUnit
Evidence documents to be produced130 requirements × 3 documents390documents
Interviews and reviews to be conducted20 processes × 240interviews
Awareness sessions85 people ÷ 15, rounded up6sessions
Control points to be updated130 requirements × 20 processes2 600points
The diagnosis

What we measure first

Complex regulation

Companies must comply with strict standards, which can slow down innovation and increase costs.

Increased competition

The emergence of new players and generic products intensifies competition in the market.

Evolution of consumer expectations

Patients are seeking personalised solutions and easier access to care.

Insufficient digitalisation

Many companies have not yet fully integrated digital tools into their operations.

The work plan

How the mission unfolds

1

Improvement of regulatory compliance

Establish internal processes to monitor regulatory developments and train staff.

2

Differentiation strategies

Develop innovative products and value-added services to stand out from the competition.

3

Enhancing the customer experience

Implement digital solutions to facilitate access to information and services.

4

Strategic partnerships

Collaborate with local and international players to expand offerings and improve distribution.

5

Investment in digitalisation

Adopt digital tools to optimise operations and improve data management.

The follow-up

The indicators implemented

Identified during the diagnosis and monitored throughout the mission: these are what make the result demonstrable, not just declarative.

  • Completeness rate of the technical file by product
  • Number of discrepancies identified during inspection and their closure
  • Traceability of batches, from raw materials to the patient
  • Results of the release controls
  • Processing time for a complaint or vigilance
Clarity

What causes this type of project to fail

Regulatory non-compliance+
Companies have faced penalties due to a lack of adherence to current standards.
Innovation failure+
Some companies have failed to develop new products, resulting in a loss of market share.
Poor management of customer experience+
Negative feedback has been recorded due to limited access to services and information.
Delay in digitalisation+
Companies have lost competitiveness by not adopting digital tools in time.
Frequently Asked Questions

What is being asked of us

How can regulatory compliance be improved in the sector?+
You must establish a regulatory monitoring system and regularly train staff on new standards.
What strategies should be adopted to differentiate from the competition?+
Investing in product innovation and offering personalised services can help stand out in the market.
Why is it important to enhance customer experience?+
A good customer experience fosters loyalty and can enhance the company's reputation.
How can digitalisation benefit businesses?+
Digitalisation allows for the optimisation of processes, reduction of costs, and improved access to information for customers.

Let's redo this calculation with your figures

The diagnosis replaces each hypothesis with data collected from you. It lasts half a day and does not commit you to anything.

Request a diagnosis